Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats

Journal of Laboratory and Clinical Medicine

Volumn 127, Issue 3, 1996, Pages 263-271

  Su, Tony H ^b   Natarajan, Viswanathan ^b   Kachel, Diane L ^b   Moxley, Michael A ^b   Longmore, William J ^b   Martin II, William J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; PHOSPHATIDYLGLYCEROL; PHOSPHOLIPID;

ANIMAL; ARTICLE; CHEMISTRY; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; LUNG LAVAGE; PATHOPHYSIOLOGY; PHYSIOLOGY; PNEUMOCYSTIS PNEUMONIA; RAT; TIME;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; IMMUNOSUPPRESSION; LIPIDS; PHOSPHATIDYLGLYCEROLS; PHOSPHOLIPIDS; PNEUMONIA, PNEUMOCYSTIS; RATS; RATS, INBRED LEW; TIME FACTORS;

EID: 0030091961     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90094-3     Document Type: Article

References (49)

1. Hughes W. Pneumocystis carinii pneumonia. N Engl J Med 1977;297:1381-3.
2. Hopewell CH, Luce JM. Pulmonary involvement in the acquired immunodeficiency syndrome. Chest 1985;87:104-12.
3. Harwood JL, Desai R, Hext P, Tetley T, Richards R. Characterization of pulmonary surfactant from ox, rabbit, rat, and sheep. Biochem J 1975;151:707-14.
4. Dobbs LG, Mason RJ, Williams MC, Benson BJ, Sueishi K. Secretion of surfactant by primary cultures of alveolar type II cells isolated from rats. Biochim Biophys Acta 1982;713:118-27.
5. Hawgood S. Surfactant: composition, structure, and metabolism. Crystal RG, West JB, Barnes PJ, Weibel ER, Cherniack NS, eds. The lung: scientific foundations. New York: Raven Press Ltd., 1991:247-61.
6. Hawgood S, Shiffer K. Structures and properties of the surfactant-associated proteins. Annu Rev Physiol 1991;53:375-94.
7. McNeal JE, Yaeger RG. Observations on a case of Pneumocystis carinii pneumonia. Arch Pathol 1960;53:375-94.
8. Tran Van Nhieu J, Vojtek A, Bernaudin J, Escudier E, Fleury-Feith J. Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Chest 1990;98:801-5.
9. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJ II. 120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest 1992;89:143-9.
10. Kernbaum S, Masliah J, Alcindor LC, Bouton C, Cristol D. Phospholipase activity of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia. Br J Exp Pathol 1983;64:75-80.
11. 2 in experimental Pneumocystis carinii. Am Rev Respir Dis 1986;134:526-31.
12. Boylan CJ, Current WL. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in pneumocystis-free animals. Infect Immun 1992;60:1589-97.
13. Masur H, Jones TC. The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med 1978;147: 157-70.
14. Bartlett MS, Vervanec PA, Smith JW. Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol 1979;10: 796-9.
15. Bligh EG, Dyer WG. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-7.
16. Bartlett MS. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-8.
17. Gilfillan AM, Chu AJ, Smart DA, Rooney SA. Single plate separation of lung phospholipids including disaturated phosphatidylcholine. J Lipid Res 1983;24:1651-6.
18. Epps DE, Natarajan V, Schmid PC, Schimd HO. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 1980;618:420-30.
19. Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol: Respirat Environ Exercise Physiol 1977;43:198-203.
20. Dobbs LG, Wright JR, Hawgood S, Gonzalez R, Venstrom K, Nellenbogen J. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci USA 1987;84: 1010-4.
21. Phelps DS, Rose RM. Increased recovery of surfactant protein A in AIDS-related pneumonia. Am Rev Respir Dis 1991;143:1072-5.
22. Stokes D, Hughes W, King R. Model of Pneumocystis carinii pneumonia: changes in lung compliance. Am Rev Respir Dis 1981;123:163a.
23. Escamilla R, Prevost M-C, Hermant C, Caratero A, Cariven C, Krempf M. Surfactant analysis during Pneumocystis carinii pneumonia in HIV-infected patients. Chest 1992;101:1558-62.
24. Pesanti EL. Phospholipid profile of Pneumocystis carinii and its interaction with alveolar type II epithelial cells. Infect Immun 1987;55:736-41.
25. Rice WR, Singleton FM, Linke MJ, Walzer PD. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J Clin Invest 1993;92:2778-82.
26. Liau DF, Barrett CR, Bell ALL, Cernansky G, Ryan SF. Diphosphatidylglycerol in experimental acute alveolar injury in the dog. J Lipid Res 1984;21:1004-14.
27. Rooney SA. The surfactant system and lung phospholipid biochemistry. Am Rev Respir Dis 1985;131:439-60.
28. Hallman M, Enhorning G, Possmayer F. Composition and surface activity of normal and phosphatidylglycerol-deficient lung surfactant. Pediatr Res 1985;19:286-92.
29. Oyarzun MJ, Clements JA, Baritussio A. Ventilation enhances pulmonary alveolar clearance of radioactive dipamitoyl-phosphatidylcholine in liposomes. Am Rev Respir Dis 1980;121:709-21.
30. Bates SR, Ibach PB, Fisher AB. Phospholipids co-isolated with rat surfactant protein C account for the apparent protein-enhanced uptake of liposomes into lung granular pneumocytes. Exp Lung Res 1981;15:695-708.
31. Wherrett JR, Huterer S. Bis-(monoacylglyceryl)-phosphate of rat and human liver: fatty acid composition and NMR spectroscopy. Lipids 1973;8:531-3.
32. Yamamoto A, Adachi S, Ishibe T, et al. Accumulation of acidic phospholipids in a case of hyperlipidemia with hepatosplenomegaly. Lipids 1970;5:556-71.
33. Simon G, Rouser G. Species variations in phospholipid class distribution of organs. II. Heart and skeletal muscle. Lipids 1969;4:607-14.
34. Kahma K, Brotherus J, Haltia M, Renkonen O. Low and moderate concentrations of lysobisphosphatidic acid in brain and liver of patients affected by some storage diseases. Lipids 1976;11:539-44.
35. Martin II WJ, Kachel DL, Vilen T, Natarajan V. Mechanism of phospholipidosis in amiodarone pulmonary toxicity. J Pharmacol Exp Ther 1989;251:272-8.
36. Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev 1990;42:327-54.
37. Waite M, King L, Thornburg T, Osthoff G, Thuren TY. Metabolism of phosphatidylglycerol and bis(monoacylglycero)-phosphate in macrophage subcellular fractions. J Biol Chem 1990;265:21720-6.
38. Gluck L, Kulovich MV, Borer Jr RC, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory syndrome by amniocentesis. Am J Obstet Gynecol 1971;109:440-5.
39. Hallman M, Feldman BH, Kirkpatrick E, Gluck L. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatr Res 1977;11:714-20.
40. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L. Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity and plasma myoinositol. J Clin Invest 1982;70:673-83.
41. Pison U, Seeger W, Buchhorn R, et al. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989;140:1033-9.
42. Pison U, Obertacke U, Brand M, et al. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990;30:19-26.
43. Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88:1976-81.
44. 2. and pneumonia-induced lung injury II: properties of pulmonary surfactant. J Appl Physiol 1989;67:357-65.
45. Liau DF, Barrett CR, Bell ALL, Ryan SF. Normal surface properties of phosphatidylglycerol-deficient surfactant from dog after acute lung injury. J Lipid Res 1985;26:1338-44.
46. Thrall RS, Swendsen CL, Shannon TH, et al. Correlation of changes in pulmonary surfactant phospholipids with compliance in bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis 1987;136:113-8.
47. Suzuki Y, Tabata R. Selective reduction of phosphatidylglycerol and phosphatidylcholine in pulmonary surfactant by 4-aminopyrazolo(3,4)pyrimidine in the rat. J Lipid Res 1980; 21:1090-6.
48. Liau DF, Barrett CR, Bell ALL, Ryan SF. Functional abnormalities of lung surfactant in experimental acute alveolar injury in the dog. Am Rev Respir Dis 1987;136:395-401.
49. Eijking EP, van Daal GJ, Tenbrinck R, et al. Effect of surfactant replacement on Pneumocystis carinii pneumonia on rats, Intensive Care Med 1991;17:475-8.